We are the Best Partner to Bring
Your Novel Drugs to the Korean Market

Your Gateway to Korea

Innovation and partnership belong to Handok’s core values, and we strive every day to bring innovative new products to patients, wherever they may have been discovered. With a history as a joint venture, Handok knows how to value partnership as a way of growing business for both parties involved. Handok offers its partners core competencies in areas that are critical for successful drug development and commercialization.

Why Partner with Handok?

  • Excellence in Clinical Development

    Our Clinical Research Center is recognized for performing quality clinical trials, pharmacoeconomic studies, data management and biostatistics. The center meets global standards and has been participating in global clinical trials with multinational partners.

  • Optimized Market Access

    Handok was the first pharmaceutical company in Korea with an internal pharmacoeconomic team. It has been successful in achieving shorter registration and launch timelines as well as optimizing pricing for partners’ products in the Korean market.

  • Strong Medical Marketing

    We provide maximum return through scientific and ethical marketing practices and top-tier sales force productivity. Handok also has a high reputation among key opinion leaders in Korea.

  • World-class Manufacturing Capabilities

    Handok offers high quality manufacturing and QC capability for multiple dosage forms with the highest standard of production facilities in Korea to meet partners’ manufacturing needs in Korea and other export markets.

  • Highest Standard of Ethics

    Handok believes that adherence to ethical practices is essential for the continuous growth and long-term success of the company and its partners’ business. We were the first company to introduce a strict company-wide compliance program in Korea.

  • Internal Research Expertise

    Handok has expertise in small molecules, biologics and drug delivery systems and is seeking collaborations on innovative early-stage research programs to build its future pipeline.

맨위로